SciDEX
Agora
🏠Dashboard🔬Analyses🏛The Agora🗣Debates🧬Hypotheses🏆Leaderboard⚔Arenas🔍Research Gaps⚖Compare
Exchange
📈Exchange💹Market🎯Challenges🚀Missions📊Economics
Forge
🔨Forge📊Experiments📊Benchmarks🧠Models🎮Playground
Atlas
📖Wiki🕸Knowledge Graph🗺Atlas🎯Targets📦Artifacts🧬Protein Designs📊Datasets🏥Clinical Trials📄Papers📓Notebooks🔎Search
Senate
🏛Senate📊Pipeline🎭Pantheon⚔Quests📋Specs💰Resources👥Contributors🚦Status📑Docs
Showcase
⭐Showcase📽DemoℹVision
📖

GBA Gene Therapy for Parkinson's Disease

active
wiki page Created: 2026-04-02T20:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-therapeutics-gba-gene-therapy-parki
Related Entities
therapeutics-gba-gene-therapy-parkinsons
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

📊 Evidence Profile
Evidence Balance
+0%
Certainty
100%
Debates
0
Incoming
119
Outgoing
169
0 supporting 0 contradicting 0 neutral
View full evidence profile →
Linked Artifacts (282)
mentions🔬Analysis question not specified100%
mentions🔬Synaptic pruning by microglia in early AD100%
mentions🔬TDP-43 undergoes liquid-liquid phase separation that becomes100%
mentions🔬Can speech, gait, retinal imaging, sleep, and smartphone dat100%
mentions🔬Analysis question not specified75%
mentions🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio70%
mentions🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
mentions🧪Chaperone-Mediated APOE4 Refolding Enhancement70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
mentions🧫DLB Treatment Response Biomarkers — Predicting Cholinesteras70%
mentions🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P70%
mentions🧫MLCS Quantification in Parkinson's Disease70%
related🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P70%
mentions🧫Autophagy Enhancement Drug Screening for Neurodegeneration70%
mentions🧫Experiment: Multi-Ethnic PD GWAS70%
mentions🧫Prodromal Parkinson's Disease Biomarker Development — E70%
mentions🧫Genetic Risk Modifiers in DLB Phenotype70%
mentions🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki70%
mentions🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#70%
mentions🧫GLP-1 Agonist Responder Prediction Study — Precision Medicin70%
related🔬Analysis question not specified67%
mentions🧪Smartphone-Detected Motor Variability Correction66%
mentions🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation65%
mentions🧪Enteric Nervous System Prion-Like Propagation Blockade64%
related🧫Experiment: Multi-Ethnic PD GWAS63%
related🧫Autophagy Enhancement Drug Screening for Neurodegeneration63%
related🧫GLP-1 Agonist Responder Prediction Study — Precision Medicin63%
related🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne63%
related🧫DLB Treatment Response Biomarkers — Predicting Cholinesteras63%
related🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P63%
related🧫MLCS Quantification in Parkinson's Disease63%
related🧫Genetic Risk Modifiers in DLB Phenotype63%
related🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#63%
related🧪Chaperone-Mediated APOE4 Refolding Enhancement63%
mentions🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis61%
related🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i60%
related🧫Ferroptosis Validation in Parkinson's Disease60%
related🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise60%
related🧫Combination Therapy Sequencing in Parkinson's Disease60%
related🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&60%
related🧫GLP-1 Agonist Neuroprotection Mechanism in PD60%
related🧫Peroxisomal Dysfunction Validation in Parkinson's Disea60%
related🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#60%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#60%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera60%
related🧫Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson60%
related🧫Computational Modeling of Alpha-Synuclein Propagation in PD60%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise60%
related🧫Non-Motor Symptom Progression in Parkinson's Disease — 60%
related🧫Prodromal Parkinson's Disease Biomarker Development — E60%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#60%
related🧫Chaperone-Mediated Autophagy Dysfunction in PD - Experiment 60%
related🧫Macroautophagy Dysfunction in PD - Experiment Design60%
related🧫MLCS Quantification in Parkinson's Disease60%
related🧫Cytochrome Therapeutics60%
related🧫CRISPR Gene Correction Approaches for CBS/PSP60%
related🧫Epigenetic Dysregulation Validation in Parkinson's Dise60%
related🧫Axonal Transport Dysfunction Validation in Parkinson's 60%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson60%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin60%
related🧫Experiment: Multi-Ethnic PD GWAS60%
related🧫cGAS-STING Pathway Validation Study in Parkinson's Dise60%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&60%
related🧫Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown60%
related🧫Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 60%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD60%
related🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne60%
related🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D60%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di60%
related🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim60%
related🧫Multiscale Computational Modeling of Protein Aggregation Kin60%
related🧫AAV-LRRK2 IND-Enabling Study Design60%
related🧫AAV-LRRK2 Gene Therapy IND-Enabling Study Design60%
related🧫Exercise-BDNF-Mitophagy Biomarker Study in PD60%
related🧫Antiviral Therapy Trial for Parkinson's Disease60%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag60%
related🧫Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper60%
related🧫Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me60%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'60%
related🧫Alpha-Synuclein Seed Amplification Assay Validation60%
related🧫Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr60%
related🧫Synaptic Mitochondrial Resilience Enhancement for Parkinson&60%
related🧫Sirtuin Dysfunction Validation in Parkinson's Disease60%
related🧫Validation: Membrane-Nucleation in iPSC Neurons60%
related🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio60%
related🧫Parkinson's Disease Subtype Classification — Precision 60%
related🧫Peroxisome Dysfunction Validation in Parkinson's Diseas60%
related🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa60%
related🧫Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation60%
related🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki60%
related🧫Alpha-Synuclein SAA Kinetics Study — Biological Staging Back60%
related🧫Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation60%
related🧪Smartphone-Detected Motor Variability Correction59%
related🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation58%
related🧪Enteric Nervous System Prion-Like Propagation Blockade57%
related🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis55%
related🧫Peroxisome Dysfunction Validation in Parkinson's Diseas54%
related🧫Alpha-Synuclein Seed Amplification Assay Validation54%
related🧫Peroxisomal Dysfunction Validation in Parkinson's Disea54%
related🧫Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me54%
related🧫Parkinson's Disease Subtype Classification — Precision 54%
related🧫cGAS-STING Pathway Validation Study in Parkinson's Dise54%
related🧫Ferroptosis Validation in Parkinson's Disease54%
related🧫Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 54%
related🧫Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr54%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#54%
related🧫Exercise-BDNF-Mitophagy Biomarker Study in PD54%
related🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise54%
related🧫Antiviral Therapy Trial for Parkinson's Disease54%
related🧫Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson54%
related🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa54%
related🧫Combination Therapy Sequencing in Parkinson's Disease54%
related🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio54%
related🧫AAV-LRRK2 Gene Therapy IND-Enabling Study Design54%
related🧫Computational Modeling of Alpha-Synuclein Propagation in PD54%
related🧫Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper54%
related🧫Non-Motor Symptom Progression in Parkinson's Disease — 54%
related🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki54%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'54%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise54%
related🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i54%
related🧫Chaperone-Mediated Autophagy Dysfunction in PD - Experiment 54%
related🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&54%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson54%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di54%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag54%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&54%
related🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim54%
related🧫Alpha-Synuclein SAA Kinetics Study — Biological Staging Back54%
related🧫Macroautophagy Dysfunction in PD - Experiment Design54%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin54%
related🧫Validation: Membrane-Nucleation in iPSC Neurons54%
related🧫AAV-LRRK2 IND-Enabling Study Design54%
related🧫Sirtuin Dysfunction Validation in Parkinson's Disease54%
related🧫Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation54%
related🧫Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation54%
related🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D54%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD54%
related🧫Cytochrome Therapeutics54%
related🧫CRISPR Gene Correction Approaches for CBS/PSP54%
related🧫Synaptic Mitochondrial Resilience Enhancement for Parkinson&54%
related🧫Prodromal Parkinson's Disease Biomarker Development — E54%
related🧫Axonal Transport Dysfunction Validation in Parkinson's 54%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#54%
related🧫Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown54%
related🧫Multiscale Computational Modeling of Protein Aggregation Kin54%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera54%
related🧫Epigenetic Dysregulation Validation in Parkinson's Dise54%
related🧫GLP-1 Agonist Neuroprotection Mechanism in PD54%
mentions🧪Lysosomal Calcium Channel Modulation Therapy50%
related🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph50%
mentions🧪TET2-Mediated Demethylation Rejuvenation Therapy50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying senolytic therapy for age50%
related🔬How to break the GBA-alpha-synuclein bidirectional loop for 50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
mentions🧪Glial Glycocalyx Remodeling Therapy50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What cell types are most vulnerable in Alzheimer's Dise50%
mentions🧪Near-infrared light therapy stimulates COX4-dependent mitoch50%
related🔬What are the most promising therapeutic strategies for targe50%
mentions🧫Dexamethasone treatment study in α-synuclein mice50%
mentions🧪HCN1-Mediated Resonance Frequency Stabilization Therapy50%
mentions🧪Ganglioside Rebalancing Therapy50%
related🔬What are the mechanisms underlying epigenetic clocks and bio50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
mentions🧪Proteostasis Enhancement via APOE Chaperone Targeting50%
related🔬Comprehensive analysis of immune cell subtypes in neurodegen50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
mentions🧪Complement C1q Mimetic Decoy Therapy50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬The disease-associated microglia (DAM) phenotype involves TR50%
related🔬What are the mechanisms underlying sleep disruption as cause50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
mentions🧪Gamma entrainment therapy to restore hippocampal-cortical sy50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
mentions🧪PARP1 Inhibition Therapy50%
mentions🧪CYP46A1 Overexpression Gene Therapy50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
mentions🧪DNMT1-Targeting Antisense Oligonucleotide Reset50%
mentions🧪Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflam50%
mentions🧪Hypocretin-Neurogenesis Coupling Therapy50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
related🔬What are the mechanisms underlying epigenetic clocks and bio50%
related🔬What are the mechanisms underlying sleep disruption as cause50%
mentions🧪Purinergic P2Y12 Inverse Agonist Therapy50%
mentions🧪Heat Shock Protein 70 Disaggregase Amplification50%
mentions🧪GFAP-Positive Reactive Astrocyte Subtype Delineation50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
mentions🧪Circadian Glymphatic Rescue Therapy (Melatonin-focused)50%
related🔬Can gut-brain axis modulation prevent or slow Alzheimer'50%
related🔬Investigate how lipid raft composition (cholesterol metaboli50%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%
related🔬What are the mechanisms underlying selective vulnerability o50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
mentions🧪Selective Acid Sphingomyelinase Modulation Therapy50%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%
related🔬Senescent cell clearance as neurodegeneration therapy50%
related🔬What cell types are most vulnerable in Alzheimers Disease ba50%
mentions🧪R-Loop Resolution Enhancement Therapy50%
mentions🧫TLR expression in α-synuclein overexpressing mice50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
mentions🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th50%
related🔬Investigate how lipid raft composition (cholesterol metaboli50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%
mentions🧪Orexin-Microglia Modulation Therapy50%
mentions🧪Microglial Purinergic Reprogramming50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying 4r-tau strain-specific sp50%
mentions🧪SIRT6-NAD+ Axis Enhancement Therapy50%
mentions🧪Arginine Methylation Enhancement Therapy50%
mentions🧫Longitudinal TLR2 reporter gene study in α-synuclein mice50%
mentions🧫Metal Ion Homeostasis Dysregulation in Alzheimer's Dise44%
related🧪CYP46A1 Overexpression Gene Therapy40%
related🧪SIRT6-NAD+ Axis Enhancement Therapy40%
related🧪R-Loop Resolution Enhancement Therapy40%
related🧪Hypocretin-Neurogenesis Coupling Therapy40%
mentions🔬Senescent cell clearance as neurodegeneration therapy40%
mentions🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph40%
mentions🔬Can gut-brain axis modulation prevent or slow Alzheimer'40%
related🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th40%
related🧪Selective Acid Sphingomyelinase Modulation Therapy40%
related🧪Glial Glycocalyx Remodeling Therapy40%
mentions🔬What are the mechanisms underlying tdp-43 phase separation t40%
related🧪Arginine Methylation Enhancement Therapy40%
related🧪Near-infrared light therapy stimulates COX4-dependent mitoch40%
related🧪TET2-Mediated Demethylation Rejuvenation Therapy40%
mentions🔬Comprehensive analysis of immune cell subtypes in neurodegen40%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR40%
mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati40%
related🧪HCN1-Mediated Resonance Frequency Stabilization Therapy40%
mentions🔬How to break the GBA-alpha-synuclein bidirectional loop for 40%
related🧪PARP1 Inhibition Therapy40%
related🧪Purinergic P2Y12 Inverse Agonist Therapy40%
related🧪Targeted APOE4-to-APOE3 Base Editing Therapy40%
related🧪Circadian Glymphatic Rescue Therapy (Melatonin-focused)40%
mentions🔬What are the most promising therapeutic strategies for targe40%
related🧪Lysosomal Calcium Channel Modulation Therapy40%
mentions🔬What are the mechanisms underlying senolytic therapy for age40%
mentions🔬What are the mechanisms underlying what are the mechanisms b40%
related🧪Orexin-Microglia Modulation Therapy40%
mentions🔬What are the mechanisms underlying blood-brain barrier trans40%
related🧪Ganglioside Rebalancing Therapy40%
related🧪Gamma entrainment therapy to restore hippocampal-cortical sy40%
mentions🔬What cell types are most vulnerable in Alzheimers Disease ba40%
related🧪Complement C1q Mimetic Decoy Therapy40%
mentions🔬What cell types are most vulnerable in Alzheimer's Dise40%
related🧪Hypocretin-Neurogenesis Coupling Therapy35%
related🧪Cholesterol-CRISPR Convergence Therapy for Neurodegeneration35%
related🧪Miro1-Mediated Mitochondrial Trafficking Enhancement Therapy35%
related🧪Ganglioside Rebalancing Therapy35%
related🧪Targeted APOE4-to-APOE3 Base Editing Therapy35%
related🧪CYP46A1 Overexpression Gene Therapy35%
related🧪Glial Glycocalyx Remodeling Therapy35%
related🧪SIRT6-NAD+ Axis Enhancement Therapy35%
related🧪R-Loop Resolution Enhancement Therapy35%
related🧪Arginine Methylation Enhancement Therapy35%
related🧪Selective Acid Sphingomyelinase Modulation Therapy35%
related🧪APOE Isoform Conversion Therapy35%
related🧪PARP1 Inhibition Therapy35%
related🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th35%
related🧪Near-infrared light therapy stimulates COX4-dependent mitoch35%
related🧪Orexin-Microglia Modulation Therapy35%
related🧪Lysosomal Calcium Channel Modulation Therapy35%
related🧪Gamma entrainment therapy to restore hippocampal-cortical sy35%
related🧪APOE4-Selective Lipid Nanoemulsion Therapy35%
related🧪Liquid-Liquid Phase Separation Modifier Therapy35%
related🧪HCN1-Mediated Resonance Frequency Stabilization Therapy35%
related🧪TET2-Mediated Demethylation Rejuvenation Therapy35%
related🧪Complement C1q Mimetic Decoy Therapy35%
related🧪Circadian Glymphatic Rescue Therapy (Melatonin-focused)35%
related🧪RNA-Binding Competition Therapy for TDP-43 Cross-Seeding35%
related🧪Purinergic P2Y12 Inverse Agonist Therapy35%
related🔬What are the mechanisms underlying 4r-tau strain-specific sp30%
related🔬What are the mechanisms underlying selective vulnerability o30%

💬 Discussion

SciDEX — scidex.ai — Dashboard | Mission Control | Status | How it Works | GitHub